Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic ApproachPaola Orlandi, Anna Solini, Marta Banchi, et al.
Cardiovascular Diabetology|September 4, 2012
Adipocytokine levels mark endothelial function in normotensive individualsAnna Solini, Francesco Stea, Eleonora Santini, et al.
Diabetes|November 8, 2023
Role of Glycosuria in SGLT2 Inhibitor-Induced Cardiorenal Protection: A Mechanistic Analysis of the CREDENCE TrialEle Ferrannini, Anna Solini, Simona Baldi, et al.
Diabetes/Metabolism Research and Reviews|October 15, 2023
Simple proxies of insulin resistance identify obese metabolic dysfunction-associated fatty liver disease subjects with advanced liver diseaseGiovanni Petralli, Antonio Salvati, Domenico Tricò, et al.
Obesity Facts|October 5, 2016
Metabolic and Hormonal Determinants of Glomerular Filtration Rate and Renal Hemodynamics in Severely Obese IndividualsEdoardo Vitolo, Eleonora Santini, Antonio Salvati, et al.
The Lancet Regional Health. Europe|February 8, 2024
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal riskGian Paolo Fadini, Enrico Longato, Mario Luca Morieri, et al.
Cardiovascular Diabetology|November 6, 2022
Synergistic effect of chronic kidney disease, neuropathy, and retinopathy on all-cause mortality in type 1 and type 2 diabetes: a 21-year longitudinal studyLuca Sacchetta, Martina Chiriacò, Lorenzo Nesti, et al.
Diabetes Care|February 14, 2023
Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal StudyDiego Moriconi, Luca Sacchetta, Martina Chiriacò, et al.
The Journal of Clinical Endocrinology and Metabolism|February 16, 2023
Empagliflozin and Renal Sodium-Hydrogen Exchange in Healthy SubjectsEdoardo Biancalana, Chiara Rossi, Francesco Raggi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 25, 2004
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetesAnna Solini, Paola Chiozzi, Anna Morelli, et al.
Pageof 17